Tempus Product Theater Presentation* from the 2023 San Antonio Breast Cancer Symposium
Integrating AI-Enabled Technology and Comprehensive Molecular Profiling to Enhance Breast Cancer Care
Hear from Dr. Rebecca Shatsky of UC San Diego Health and Dr. Calvin Chao of Tempus as they explore the latest advancements for enabling precision oncology and discuss recent research findings, breakthroughs in molecular profiling, the expansion of our liquid biopsy portfolio and the impact AI-enabled technological innovations have on reshaping the advanced breast cancer landscape.
*This Exhibitor Product Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Product Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium® (SABCS®).
Related content


